Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Hum Immunol. 2012 May 17;73(8):783–787. doi: 10.1016/j.humimm.2012.05.006

Table 3.

Analysis of KIR3DS1 and HLA-Bw480I Influence on Disease Outcome in Brazilian HTLV-1 Cohort


AS HAM/TSP

n % n % Odds Ratio [95% CI] P Value

3DS1 145 27.3 71 30.3 1.18 [0.64–2.18] 0.59
Bw480I 145 59.3 71 68.8 1.19 [0.63–2.23] 0.59
3DS1 + Bw480I 145 16.6 71 18.3 1.13 [0.60–2.15] 0.7